TY - JOUR
T1 - Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model
AU - Martinu, Tereza
AU - Oishi, Hisashi
AU - Juvet, Stephen C.
AU - Cypel, Marcelo
AU - Liu, Mingyao
AU - Berry, Gerald J.
AU - Hwang, David M.
AU - Keshavjee, Shaf
N1 - Funding Information:
The authors thank Paul Chartrand, manager of the Latner Thoracic Surgery Research Laboratories, for facilitating experiment logis‐ tics. Funding support from ISHLT Norman E. Shumway Career Development award (to TM), Parker B Francis award (to TM), Canadian Cystic Fibrosis Foundation Operating Grant #2387 (to SK).
Publisher Copyright:
© 2018 The American Society of Transplantation and the American Society of Transplant Surgeons
PY - 2019/1
Y1 - 2019/1
N2 - Chronic lung allograft dysfunction (CLAD) is a fatal condition that limits survival after lung transplantation (LTx). The pathological hallmark of CLAD is obliterative bronchiolitis (OB). A subset of patients present with a more aggressive CLAD phenotype, called restrictive allograft syndrome (RAS), characterized by lung parenchymal fibrosis (PF). The mouse orthotopic single LTx model has proven relevant to the mechanistic study of allograft injury. The minor-alloantigen-mismatched strain combination using C57BL/10(B10) donors and C57BL/6(B6) recipients reportedly leads to OB. Recognizing that OB severity is a spectrum that may coexist with other pathologies, including PF, we aimed to characterize and quantify pathologic features of CLAD in this model. Left LTx was performed in the following combinations: B10→B6, B6→B10, B6→B6. Four weeks posttransplant, blinded pathologic semi-quantitative assessment showed that OB was present in 66% of B10→B6 and 30% of B6→B10 grafts. Most mice with OB also had PF with a pattern of pleuroparenchymal fibroelastosis, reminiscent of human RAS-related pathology. Grading of pathologic changes demonstrated variable severity of airway fibrosis, PF, acute rejection, vascular fibrosis, and epithelial changes, similar to those seen in human CLAD. These assessments can make the murine LTx model a more useful tool for further mechanistic studies of CLAD pathogenesis.
AB - Chronic lung allograft dysfunction (CLAD) is a fatal condition that limits survival after lung transplantation (LTx). The pathological hallmark of CLAD is obliterative bronchiolitis (OB). A subset of patients present with a more aggressive CLAD phenotype, called restrictive allograft syndrome (RAS), characterized by lung parenchymal fibrosis (PF). The mouse orthotopic single LTx model has proven relevant to the mechanistic study of allograft injury. The minor-alloantigen-mismatched strain combination using C57BL/10(B10) donors and C57BL/6(B6) recipients reportedly leads to OB. Recognizing that OB severity is a spectrum that may coexist with other pathologies, including PF, we aimed to characterize and quantify pathologic features of CLAD in this model. Left LTx was performed in the following combinations: B10→B6, B6→B10, B6→B6. Four weeks posttransplant, blinded pathologic semi-quantitative assessment showed that OB was present in 66% of B10→B6 and 30% of B6→B10 grafts. Most mice with OB also had PF with a pattern of pleuroparenchymal fibroelastosis, reminiscent of human RAS-related pathology. Grading of pathologic changes demonstrated variable severity of airway fibrosis, PF, acute rejection, vascular fibrosis, and epithelial changes, similar to those seen in human CLAD. These assessments can make the murine LTx model a more useful tool for further mechanistic studies of CLAD pathogenesis.
KW - basic (laboratory) research/science
KW - bronchiolitis obliterans (BOS)
KW - fibrosis
KW - lung (allograft) function/dysfunction
KW - lung transplantation/pulmonology
KW - rejection
KW - rejection: chronic
KW - translational research/science
UR - http://www.scopus.com/inward/record.url?scp=85057830877&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85057830877&partnerID=8YFLogxK
U2 - 10.1111/ajt.15167
DO - 10.1111/ajt.15167
M3 - Article
C2 - 30378739
AN - SCOPUS:85057830877
SN - 1600-6135
VL - 19
SP - 247
EP - 258
JO - American Journal of Transplantation
JF - American Journal of Transplantation
IS - 1
ER -